Collaborating to Provide Real-world Patient-care Strategies for Type 2 Diabetes: Optimizing the Use of GLP-1 RAs

The France Foundation (TFF), the American College of Osteopathic Family Physicians (ACOFP), and the California Academy of Family Physicians (CAFP) have developed education to help primary care providers and advanced practice professionals optimize GLP-1 receptor agonists (GLP-1 RAs) in managing patients with Type 2 Diabetes (T2D): “GLP-1 RAs: Real-world Patient-care Strategies for Type 2 Diabetes.”

Diabetes is one of the most common health crises in the United States. It’s the seventh-leading cause of death, fifth-most common diagnosis in primary care, and the number one cause of kidney failure, lower-limb amputations, and blindness in adults. In the US, there are more than 30 million people with diabetes, with 95% having Type 2 diabetes. The vast majority of these individuals are seen and managed in primary care practices.

Beyond lifestyle changes and initial medications, GLP-1 RAs play a crucial role in the management of T2D. Despite their elevation to first-line monotherapy, larger studies have shown that only between 1.8% and 7% of newly diagnosed patients receive GLP-1 RAs.

Diabetes specialists Dr. Jay Shubrook from Touro University, CA, and Dr. Leslie Goldstein from the New York Institute of Technology, NY, offer advice on leveraging patient preferences and treatment guidelines to choose the most suitable GLP-1 receptor agonists for patients with type 2 diabetes (T2D). Participants can learn how to distinguish between available GLP-1 receptor agonists based on their therapeutic characteristics, as well as develop strategies to address potential side effects associated with these medications.

Interested in this CME/CE program? START HERE

ACOFP is a community of physicians who champion osteopathic principles while putting patients first. They provide educational resources to over 25,000 practicing osteopathic family physicians, residents, and students throughout the US , and have partnered with TFF in other diabetes education such as “The Patient Perspective: Continuous Glucose Monitoring (CGM ).”

Likewise, CAFP is committed to advocating for family medicine professionals and advancing the specialty of family medicine through charitable efforts that aim to improve access to learning and networking opportunities.

We’re thrilled to collaborate with these accomplished organizations on this educational program and intend to provide more opportunities in the future for family physicians across the country.

If you would like to partner with The France Foundation on future educational activities, please Contact Us.

To learn more about ACOFP, visit their website:

To learn more about CAFP, visit their website:

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA